Resources

2 Resources for

cialis

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

The Top 5 Most Recalled Drug Ads of 2008
The Cialis bathtub couple still rules: Eli Lilly produced three of the top five most memorable drug ads of 2008, according to Nielsen IAG, including one for Cialis. Warner Chilcott and the joint venture of Bristol-Myers Squibb and Sanofi-Aventis for Plavix produced the other two. IAG describes...
Tags: Eli Lilly & Co., Advertisement, Beach, Cialis, Nielsen IAG, IAG, Jim Edwards
Blog posts 2009-04-01
Cialis Goes Up Against Viagra in Hypertension Add-On War
United Therapeutics has begun marketing a pulmonary arterial hypertension drug, Adcirca, made from Eli Lilly's Cialis ED drug, according to Investor's Business Daily. It will compete with Pfizer's Revatio, a PAH drug made from Viagra. by Jim Edwards
Tags: Viagra, Cialis, United Therapeutics, Marketing Research, Marketing, Jim Edwards
Blog posts 2009-08-18

Additional Resources

ELI LILLY AND COMPANY APPROVED TO LAUNCH CIALIS IN CHINA
AsiaInfo Services 04-20-2005 Eli Lilly and Company Approved to Launch Cialis in China BEIJING, Apr 20, 2005 SinoCast via COMTEX -- The US medicine producer Eli Lilly and Company has received approval to roll out Cialis, a new product for curi...
Tags: Eli Lilly & Co.
Research articles 2005-04-20
ELI LILLY AND COMPANY LAUNCHES CIALIS IN CHINA
AsiaInfo Services 06-03-2005 Eli Lilly and Company Launches Cialis in China BEIJING, Jun 03, 2005 SinoCast via COMTEX -- The US medicine producer Eli Lilly and Company posted an announcement that it has launched Cialis,the product for curing AsiaInfo...
Tags: Eli Lilly & Co.
Research articles 2005-06-03
ICOS Corporation Reports Results for 2006 First Quarter; Strong Performance of Cialis Propels Near Breakeven for Quarter; Cialis Captures Leading ED Market Share in Eleven Countries in February 2006
BOTHELL, Wash. -- ICOS Corporation (Nasdaq:ICOS) today released its financial results for the three months ended March 31, 2006 and summarized recent events. E[acute accent]"ICOS is off to a strong start in 2006," stated Paul Clark, ICOS Chairman and CEO. "Cialis continues to gain market share. In March 2006, Cialis...
Research articles 2006-05-04
Lilly ICOS LLC: First Presentation of Large-Scale Integrated Analysis of Phase III Data on Cialis — tadalafil — Shows Consistent Effect in Men With Erectile Dysfunction
Business Editors and Health/Medical Writers ROME--BW HealthWire--Oct. 2, 2001 New Study Shows Cialis Absorption Not Affected by Food Intake The first presentation of a large-scale integrated analysis of Phase III data on CialisTM tadalafil, a new oral treatment for erectile dysfunction ED being developed by Lilly ICOS...
Tags: analysis, Eli Lilly & Co., food, ICOS Corp., Manufacturing, patient, U.S. Congress
Research articles 2001-10-02
Ads for Viagra Competitor Cialis to Focus on Results, Not Celebrities.
By Luke Timmerman, The Seattle Times Knight Ridder/Tribune Business News Oct. 10--Viagra has baseball star Rafael Palmeiro. Competitor Levitra has former NFL coach Mike Ditka. Cialis will have no one you've ever heard of. The creators of Cialis -- Bothell-based...
Tags: Seattle Times Co.
Research articles 2003-10-10
Tadalafil. (Pharma in Brief).(Lilly ICOS LLC receives approval for PDE5 inhibitor, Cialis)(Brief Article)
TADALAFIL Lilly ICOS LLC has received European Commission approval for Cialis, an oral PDE5 inhibitor to treat erectile dysfunction. Lilly is transferring the late stages of manufacturing (i.e., ... TADALAFIL Lilly ICOS LLC has received European Commission approval for Cialis, an oral PDE5 inhibitor...
Tags: European Commission, Lilly
Research articles 2002-11-25
Lilly signs UK shops for Cialis promotion
Eli Lilly is using the professional agency Norris Lincoln Adcom to support its launch of Cialis in the United Kingdom. Cialis, which is the first anti-impotence drug to compete with Pfizer blockbuster Viagra, was launched in the United Kingdom in February. The new drug is expected to be approved in...
Tags: Pfizer Inc.
Research articles 2003-03-01
Lilly offers to pay for Viagra for customers dissatisfied with new rival Cialis
NEW YORK AFP ? Stepping up the war of erectile dysfunction drugs, Eli Lilly said it would pay for competing treatments if customers are not satisfied with its new product called Cialis. The move marked an unusual step as Lilly and its partner Icos try to grab market share...
Tags: Agence France-Presse, Biotechnology, Eli Lilly & Co., Lilly, Viagra
Research articles 2004-07-12
Lilly ICOS LLC. (Active Pharmaceutical Ingredient Watch).(European Commission approval for Cialis)(Brief Article)
LILLY ICOS LLC has received approval by the European Commission EC for Cialis tadalafil, in all 15-member states of the European Union. Cialis is an oral PDE5 inhibitor for the treatment of erectile dysfunction.
Tags: European Commission
Research articles 2002-12-02
Lilly to absorb biotech firm, get full rights to Cialis
NEW YORK AFP — US pharmaceutical group Eli Lilly and Co. said it struck a deal to acquire biotech group ICOS Corp., thereby getting full rights to the blockbuster erectile dysfunction drug Cialis. The deal calls for Lilly, based in Indianapolis, Indiana, to acquire all of the outstanding shares of...
Tags: Agence France-Presse, Biotechnology, Lilly
Research articles 2006-10-17
Ad for Lilly's Impotence Drug Cialis to Air during NFL Semifinals.
By Jeff Swiatek, The Indianapolis Star Knight Ridder/Tribune Business News Jan. 16--A television commercial showing a couple discreetly reclining in two open-air bathtubs will kick off advertising this weekend for Cialis, the male impotence drug marketed by Eli Lilly and Co....
Tags: advertisement, NFL, Viagra
Research articles 2004-01-16
Swiss Allege Price Fixing on Viagra and Cialis
Swiss authorities have accused Pfizer and Eli Lilly of conspiring to fix prices for Viagra and Cialis. The news has created the best Bloomberg headline ever: "Pfizer, Lilly, Bayer Operated Erection-Drug Cartel, Swiss Say." A couple of days ago BNET noted that Pfizer and Lilly appear to...
Tags: Bayer AG, Pfizer Inc., Viagra, Lilly, Vertical Industries, Benefits, Healthcare, Sales Strategy, Sales Force Management, Enterprise Software, Software, Human Resources, Sales, Jim Edwards
Blog posts 2009-02-10
Bothell, Wash.-based Icos reassures investors about Cialis drug sales.
By Luke Timmerman, The Seattle Times Knight Ridder/Tribune Business News Aug. 5--Icos tried to reassure investors yesterday that it's not overspending on marketing and that growing sales of its erectile-dysfunction drug Cialis could push it into profitable territory in two years....
Tags: Seattle Times Co.
Research articles 2004-08-05
ICOS Corporation Reports Results for Third Quarter of 2004; Cialis US Sales Increased 38% Over Previous Quarter to $70 Million
BOTHELL, Wash. -- 2004 Year-to-Date Worldwide Cialis Sales Top $399 Million
Tags: sales
Research articles 2004-11-04
Eli Lilly and Sanofi partner on Cialis
ELI LILLY & CO. IS partnering with Sanofi-Aventis to market erectile-dysfunction drug Cialis tadalafil to US urologists.
Tags: Eli Lilly & Co.
Research articles 2008-05-01
Pharma Roundup: Obama May Decrease Drug Revenue, Strong Viagra and Cialis Sales, and More
Obama health plan provision could cost pharma billions in revenue; Viagra and Cialis sales still swelling; Glaxo opts for transparency; contract manufacturing worth $20 billion by John Maas
Tags: Revenue, Pharmaceutical Company, Health Care, Viagra, Vertical Industries, Benefits, Healthcare, Manufacturing, Enterprise Software, Software, Human Resources, John Maas, Obama Health Plan
Blog posts 2008-10-23
Viagra, Cialis, Levitra works for diabetics: study
CHICAGO AFP — Viagra, Cialis and Levitra, wildly popular erectile dysfunction drugs, can improve sexual function in men with diabetes, a study said. Diabetic men are three times more likely to suffer from impotence than their peers because of damage to nerves and blood vessels. In addition, their greater greater...
Tags: Agence France-Presse, HEALTHCARE, Viagra
Research articles 2007-01-23
New hearing loss warnings set for Viagra, Levitra, Cialis
WASHINGTON AFP — The US Food and Drug Administration has decided to put more prominent warnings of potential hearing loss on impotence drugs Viagra, Cialis and Levitra. An FDA statement said the goal was "to display more prominently the potential risk of sudden hearing loss, and to guide consumers...
Tags: Agence France-Presse, FDA, Government, Viagra
Research articles 2007-10-19
  • << Previous
  • page 1 of 1
  • Next >>
advertisement
advertisement
Click Here